AEON Biopharma
AEON
AEON
26 hedge funds and large institutions have $103M invested in AEON Biopharma in 2024 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
+7
Holders Change %
+36.84%
% of All Funds
0.38%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
8
Increased
10
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.37M |
| 2 |
Goldman Sachs
New York
|
+$1.75M |
| 3 |
Millennium Management
New York
|
+$649K |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$648K |
| 5 |
State Street
Boston,
Massachusetts
|
+$574K |
